Literature DB >> 27529370

KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.

Arcangela G Manente1, Giulia Pinton, Sara Zonca1, Daniela Tavian2, Tanwir Habib3, Puthen V Jithesh3, Dean Fennell4, Stefan Nilsson5, Laura Moro1.   

Abstract

AIM: To assess the correlation between KDM6B and estrogen receptor β (ERβ) expression in malignant pleural mesothelioma (MPM). MATERIALS &
METHODS: We evaluated gene expression by in silico analysis of microarray data, real-time PCR and western blot in MPM tumors and cell lines. RESULTS &
CONCLUSION: We report a strong positive correlation between the expression of KDM6B and ERβ in MPM tumors and cell lines. We describe that, in hypoxia, the HIF2α-KDM6B axis induces an epithelioid morphology and ERβ expression in biphasic MPM cells with estrogen receptor-negative phenotype. Reduced histone H3K27 tri-methylation confirms KDM6B activity under hypoxic conditions. Importantly, cells treated during reoxygenation with the selective ERβ agonist, KB9520, maintain ERβ expression and the less aggressive phenotype acquired in hypoxia.

Entities:  

Keywords:  ERβ; H3K27me3; KDM6B; epigenetic; human malignant pleural mesothelioma

Mesh:

Substances:

Year:  2016        PMID: 27529370     DOI: 10.2217/epi-2016-0025

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  7 in total

1.  Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.

Authors:  Jeronimo Rafael Rodríguez-Cid; Orlando García-Acevedo; Javier Benjamin-Contreras; Diana Bonilla-Molina; Rodrigo Rafael Flores-Mariñelarena; Luis Martínez-Barrera; Jorge Arturo Alatorre-Alexander; Carla Paola Sanchez-Ríos; Maria Del Rosario Flores-Soto; Patricio Javier Santillan-Doherty; Erika Sagrario Peña-Mirabal
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

3.  Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality.

Authors:  Giulia Pinton; Stefan Nilsson; Laura Moro
Journal:  Oncogenesis       Date:  2018-02-09       Impact factor: 7.485

4.  Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.

Authors:  Myung-Chul Kim; Sung-Hyun Hwang; Na-Yon Kim; Hong-Seok Lee; Sumin Ji; Yeseul Yang; Yongbaek Kim
Journal:  BMC Cancer       Date:  2018-08-15       Impact factor: 4.430

5.  CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition.

Authors:  Giulia Pinton; Zhuo Wang; Cecilia Balzano; Sara Missaglia; Daniela Tavian; Renzo Boldorini; Dean A Fennell; Martin Griffin; Laura Moro
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

6.  Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma.

Authors:  Giulia Pinton; Laura Moro
Journal:  Future Sci OA       Date:  2017-02-17

7.  Potential Health Risk of Endocrine Disruptors in Construction Sector and Plastics Industry: A New Paradigm in Occupational Health.

Authors:  Aleksandra Fucic; Karen S Galea; Radu Corneliu Duca; Mounia El Yamani; Nadine Frery; Lode Godderis; Thórhallur Ingi Halldorsson; Ivo Iavicoli; Sophie Ndaw; Edna Ribeiro; Susana Viegas; Hanns Moshammer
Journal:  Int J Environ Res Public Health       Date:  2018-06-11       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.